MedTrace Logo

Hyaluronan-enriched Medium and Euploid Blastocyst Transfers

NCT06165367 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 783

Last updated 2025-03-12

No results posted yet for this study

Summary

It has been proposed that enriching transfer media with hyaluronan (EmbryoGlue medium) improves pregnancy outcomes compared with media containing lower concentrations of this molecule. However, none of previous studies included preimplantation genetic testing for aneuploidy (PGT-A) embryos. In order to investigate the impact of this hyaluronan-enriched on pregnancy outcomes, it is essential to evaluate its efficacy on euploid-only embryo transfers. The aim of the present study is to evaluate whether a short period of exposure of euploid blastocysts to EmbryoGlue prior to and during transfer positively impact on pregnancy outcomes of frozen embryo transfer (FET) cycles.

Conditions

  • Infertility
  • Implantation Rate
  • Clinical Pregnancy Rate
  • Live Birth Rate
  • Blastocysts
  • FET

Interventions

DRUG

EmbryoGlue Medium

Embryos will be exposed to hyaluronic-enriched media (EmbryoGlue) before and during embryo transfer

Sponsors & Collaborators

  • ART Fertility Clinics LLC

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
46 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-15
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • United Arab Emirates

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06165367 on ClinicalTrials.gov